Akebia Therapeutics (Germany) Probability of Future Stock Price Finishing Over 0.88
| AX9 Stock | 0.88 1.05 54.40% |
Akebia |
Akebia Therapeutics Target Price Odds to finish over 0.88
The tendency of Akebia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.88 | 90 days | 0.88 | about 8.08 |
Based on a normal probability distribution, the odds of Akebia Therapeutics to move above the current price in 90 days from now is about 8.08 (This Akebia Therapeutics probability density function shows the probability of Akebia Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Akebia Therapeutics has a beta of -2.46. This suggests as returns on its benchmark rise, returns on holding Akebia Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Akebia Therapeutics is expected to outperform its benchmark. In addition to that Akebia Therapeutics has an alpha of 2.4801, implying that it can generate a 2.48 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Akebia Therapeutics Price Density |
| Price |
Predictive Modules for Akebia Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akebia Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akebia Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akebia Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Akebia Therapeutics is not an exception. The market had few large corrections towards the Akebia Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Akebia Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Akebia Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.48 | |
β | Beta against Dow Jones | -2.46 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | 0.23 |
Akebia Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Akebia Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Akebia Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Akebia Therapeutics generated a negative expected return over the last 90 days | |
| Akebia Therapeutics has high historical volatility and very poor performance | |
| Akebia Therapeutics has some characteristics of a very speculative penny stock | |
| Akebia Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 213.58 M. Net Loss for the year was (282.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Akebia Therapeutics generates negative cash flow from operations |
Akebia Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Akebia Stock often depends not only on the future outlook of the current and potential Akebia Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akebia Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 177 M | |
| Short Long Term Debt | 97.5 M |
Akebia Therapeutics Technical Analysis
Akebia Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Akebia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Akebia Therapeutics. In general, you should focus on analyzing Akebia Stock price patterns and their correlations with different microeconomic environments and drivers.
Akebia Therapeutics Predictive Forecast Models
Akebia Therapeutics' time-series forecasting models is one of many Akebia Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Akebia Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Akebia Therapeutics
Checking the ongoing alerts about Akebia Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Akebia Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Akebia Therapeutics generated a negative expected return over the last 90 days | |
| Akebia Therapeutics has high historical volatility and very poor performance | |
| Akebia Therapeutics has some characteristics of a very speculative penny stock | |
| Akebia Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 213.58 M. Net Loss for the year was (282.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Akebia Therapeutics generates negative cash flow from operations |
Additional Tools for Akebia Stock Analysis
When running Akebia Therapeutics' price analysis, check to measure Akebia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Therapeutics is operating at the current time. Most of Akebia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akebia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Therapeutics' price. Additionally, you may evaluate how the addition of Akebia Therapeutics to your portfolios can decrease your overall portfolio volatility.